Literature DB >> 17308

Paradoxical response to dopamine agonists in tardive dyskinesia.

B J Carroll, G C Curtis, E Kokmen.   

Abstract

The authors conducted an extensive pharmacological analysis of a patient severely affected by tardive dyskinesia. No drug treatment gave lasting clinical improvement. Several agents recently recommended for this condition, dimethyl aminoethanol, clozapine, and thioridazine, failed to modify the dyskinesia. Reserpine caused a worsening of the symptoms. A paradoxical and unexpected improvement was observed with apomorphine injections and with low-dosage oral L-dopa. These two drugs may have acted by stimulating presynaptic inhibitory dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17308     DOI: 10.1176/ajp.134.7.785

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  18 in total

Review 1.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  On the selectivity and specificity of the antagonism of apomorphine-induced suppression of exploration by sulpiride.

Authors:  L Ståhle; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patients.

Authors:  D Naber; M Leppig; R Grohmann; H Hippius
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Tolerability of long term clozapine treatment.

Authors:  M Schmauss; R Wolff; A Erfurth; E Rüther
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 5.  Do autoreceptors mediate dopamine agonist--induced yawning and suppression of exploration? A critical review.

Authors:  L Ståhle
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  EMD 23,448: effects of a putative dopamine autoreceptor agonist in chorea.

Authors:  R P Newman; C A Tamminga; T N Chase; P A LeWitt
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

7.  Sustained levodopa therapy in tardive dyskinesia.

Authors:  R J Hardie; A J Lees; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

8.  What's new in the psychopharmacology of schizophrenia.

Authors:  A Rifkin; F Quitkin
Journal:  Bull N Y Acad Med       Date:  1978-10

9.  Oral dyskinesia in rats following brain lesions and neuroleptic drug administration.

Authors:  L M Gunne; J Growdon; B Glaeser
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias.

Authors:  J E Häggström; L M Gunne; A Carlsson; H Wikström
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.